Japan Safety Syringes Market Growth Forecast 2025-2033: Rising Incidence of Chronic Diseases and Stringent Safety Regulations Fuel Market Expansion | DataM Intelligence

The Japan Safety Syringes Market was valued at US$ 228.3 million in 2024 and is projected to reach US$ 553.2 million by 2030, growing at a CAGR of 7.6% during the forecast period (2024-2030). Market growth is driven by the rising emphasis on infection control, increasing cases of chronic diseases requiring regular injections, and the growing demand for safe and reliable medical devices across hospitals and home healthcare settings.

The market is strategically positioned within Japan's healthcare safety and medical consumables industry, as "safety syringes" play a pivotal role in minimizing needlestick injuries and ensuring compliance with stringent regulatory standards. With continuous advancements in auto-disable and retractable syringe technologies, coupled with strong government support for safer healthcare practices, Japan is emerging as a leading hub for medical device innovation and patient safety solutions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/safety-syringes-market?sai-v

The safety syringes market involves specially designed syringes equipped with safety mechanisms to prevent needlestick injuries, ensuring safer injection practices for healthcare professionals and patients.

Key Developments

✅ January 2025 (Japan): Major medical-device firms in Japan expanded production of safety-engineered syringes featuring retractable needles and auto-disable mechanisms to meet growing demand in hospitals and home-care settings.

✅ November 2024 (Japan): Healthcare facilities across Japan began switching to safety syringes as part of national efforts to reduce needlestick injuries among healthcare workers and patients, supported by regulatory focus on injection safety.

✅ July 2024 (Japan): Reports indicated that the safety syringes segment was the largest revenue-generating type within Japan's disposable syringes market, reflecting strong uptake of safety devices over conventional syringes.

Mergers & Acquisitions

✅ October 2024 (Japan): A Japanese medical-device company entered a strategic alliance with an overseas manufacturer of safety syringe systems to co-develop next-generation retractable-needle syringes for the Japanese market.

✅ May 2024 (Japan): A domestic injection-device firm acquired a smaller Japanese supplier specialising in safety-syringe components (e.g., needle shields and locking mechanisms) to strengthen its integrated supply chain for safety-engineered syringes.

Market Outlook

The Japan Safety Syringes Market is expected to see steady growth driven by heightened emphasis on injection-safety, the aging population and expanding home-care and self-injection therapies. With safety syringes already established as the predominant segment in the disposable syringes market, continued regulatory support, healthcare-worker protection programmes and technological upgrades will underpin future expansion. Japan remains a key region for safety-engineered syringe adoption and innovation in Asia-Pacific.

Key Players:

Becton Dickinson & Company | Thermo Fisher Scientific | Retractable Technologies, Inc. | Terumo Corporation | Cardinal Health | B. Braun Melsungen AG | Revolutions Medical | NIPRO Medical Corporation | Sol-Millennium Inc. | AdvaCare Pharma

Key Highlights:

• Becton Dickinson & Company - Reported strong growth with advanced syringe and needle solutions, expanding its safety-engineered products portfolio across global healthcare facilities.
• Thermo Fisher Scientific - Continued innovation in laboratory and clinical consumables, enhancing precision syringe technologies for pharmaceutical and biotechnology applications.
• Retractable Technologies, Inc. - Focused on patented retractable syringe systems designed to reduce needlestick injuries and improve healthcare safety standards.
• Terumo Corporation - Recorded significant sales in medical devices with leading presence in Japan's injection and infusion therapy markets.
• Cardinal Health - Expanded its medical product offerings with advanced sterile syringe systems and global supply chain capabilities for hospital networks.
• B. Braun Melsungen AG - Strengthened its position with eco-friendly, single-use syringe technologies emphasizing patient safety and sustainability.
• Revolutions Medical - Specialized in automated injection and retractable safety syringe designs supporting infection prevention in clinical settings.
• NIPRO Medical Corporation - Increased its market share in disposable syringes and needles through high-quality manufacturing and strong distribution across Asia-Pacific.
• Sol-Millennium Inc. - Focused on developing safe injection devices, expanding its product footprint in North America, Europe, and Japan.
• AdvaCare Pharma - Enhanced its global reach with cost-effective, high-quality medical disposables including syringes and needles, serving emerging healthcare markets.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=safety-syringes-market?sai-v
(Purchase 2 or more reports and get 50% discount.)

Market Drivers & Growth:

Increasing emphasis on infection prevention and needlestick injury reduction is driving strong demand for safety syringes in Japan's healthcare sector.

Implementation of strict healthcare regulations and occupational safety standards by the Japanese Ministry of Health, Labour and Welfare (MHLW) is promoting the shift from conventional to safety-engineered syringes.

Rising number of vaccination and immunization programs, especially in response to infectious disease prevention and aging population needs, is boosting market utilization.

Growing hospital and clinical awareness about contamination risks and the importance of safe injection practices is accelerating the adoption of retractable and shielded syringes.

Expansion of home healthcare and self-injection therapies for chronic conditions such as diabetes and rheumatoid arthritis is creating sustained demand for user-friendly safety syringes.

Continuous technological advancements in syringe design, including auto-disable, passive retraction, and low-dead-space features, are improving safety and usability.

The Japan safety syringes market is poised for steady growth, supported by increasing healthcare expenditure, infection control initiatives, and ongoing innovation in medical device manufacturing.

Regional Insights:

Tokyo and Osaka lead in safety syringe adoption, driven by large hospital networks, advanced healthcare systems, and high compliance with national safety regulations.

Public hospitals and immunization centers are key end users, with procurement supported by government-led vaccination and public health campaigns.

Growing prevalence of chronic diseases in aging populations across regions like Kanto and Kansai is boosting home-use syringe demand for self-administered therapies.

Local manufacturers are investing in automated production and sterilization facilities, ensuring precision and quality compliance with Japanese and international standards.

Increasing collaborations between Japanese medical device firms and global healthcare companies are expanding product portfolios and distribution reach.

Overall, Japan's safety syringes market is expected to remain strong, driven by infection control priorities, government initiatives, and rising healthcare modernization efforts.

Key Segments:

➥ By Product Type:
Retractable Safety Syringes, Non-Retractable Safety Syringes
Retractable Safety Syringes dominate the market due to enhanced protection against needlestick injuries and improved user safety, while Non-Retractable types remain cost-effective alternatives for mass immunization programs.
Market Attractiveness: Retractable - High, Non-Retractable - Moderate.

➥ By Application:
Diabetes, Tuberculosis, HIV, Hepatitis, Others
Diabetes leads the market driven by the growing prevalence of insulin-dependent patients, while Hepatitis and HIV segments are expanding with rising vaccination and treatment programs.
Market Attractiveness: Diabetes - High, Hepatitis - Moderate, HIV - Moderate.

➥ By End-User:
Hospitals, Clinics, Ambulatory Surgical Centers, Others
Hospitals dominate as primary users owing to large-scale patient handling and vaccination drives, while Clinics and Ambulatory Surgical Centers are emerging due to increasing outpatient care.
Market Attractiveness: Hospitals - High, Clinics - Moderate, Ambulatory Surgical Centers - Moderate.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/safety-syringes-market?sai-v

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.